SynthesisEndocrine2024

Potential use of sodium glucose co-transporter 2 inhibitors during acute illness: a systematic review based on COVID-19.

Carmen Tisch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.